The phrase "a previous phase of" is correct and usable in written English.
It can be used when referring to an earlier stage or period in a process, project, or development.
Example: "In order to understand the current situation, we must analyze a previous phase of the project."
Alternatives: "an earlier stage of" or "a prior phase of".
An example is the appointment of Simon Stephens as chief executive of the NHS, who in a previous phase of his career was a hospital manager.
The program was developed in a previous phase of the Transport Research Laboratory's research into the performance of modified barriers.
Throughout the shutdown of the bikeway, which was closed from October 2006 to August 2007 during a previous phase of the bridge's overhaul, cyclists will share the walkway on the south side of the bridge with pedestrians, he said.
When combined with material imaged, transcribed and annotated in a previous phase of the project, the full collection will allow researchers and the general public to explore nearly 250 years of New England Native American history, community, culture, sovereignty, land, migration, law and politics, as well as issues of gender, race, and identity.
Where necessary (e.g., if the action was unrewarding), participants had to return to a previous phase of the problem-solving process and try to reach the goal or subgoal again.
The feel of the tune is colored with the plush musings of a previous phase of life oozing into your mind, stirring up fond memories.
Because we assume that ∼15% of the study population will be excluded during the treatment period on the basis of the results of a previous phase 3 study of azilsartan 1, 350 participants will be enrolled in each group (700 in total).
The present study was based on the promising results of a previous phase II trial of irinotecan and gemcitabine in patients with advanced/metastatic pancreatic cancer, which reported an objective response rate of 25% (Stathopoulos et al, 2003).
However, it is noteworthy that these findings are in line with a previous Phase I trial of a combination of trabectedin and carboplatin where hematologic toxicity precluded a dose increase of trabectedin beyond 800 μg/m every three weeks and carboplatin beyond an area under the concentration-time curve (AUC) of 4 mg/mL/min.
Although the effect of RO4929097 on CYP3A4 induction has been shown in a previous phase I study of RO4929097 (Tolcher et al, 2012), no evidence of autoinduction was observed in the pharmacokinetic analysis on this study.
These PR-104A AUC values were close to but lower than those (> 30 μM.hr) achieved in a previous phase I study of q 3 weekly dosing of PR-104 [ 14], and those associated with preclinical activity of PR-104 in human tumour xenograft models (> 30 μM.hr) [ 1, 2, 12].
